Zoetis Inc. (BVMF:Z1TS34)

Market Cap	282.98B
Revenue (ttm)	50.08B
Net Income (ttm)	14.13B
Shares Out	n/a
EPS (ttm)	31.64
PE Ratio	20.03
Forward PE	18.40
Dividend	0.47 (1.17%)
Ex-Dividend Date	Oct 30, 2025

Volume	141
Average Volume	3,677
Open	39.98
Previous Close	42.26
Day's Range	39.88 - 40.53
52-Week Range	39.51 - 68.38
Beta	0.96
RSI	26.57
Earnings Date	Nov 4, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: Z1TS34

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD